価格表

在庫・価格 : 2025年04月26日 08時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-PCSK9, Goat-Poly
データシート
NB300-959 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥96,000
(未発注)
追加

在庫・価格 : 2025年04月26日 08時45分 現在

Anti-PCSK9, Goat-Poly

  • 商品コード:NB300-959
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Brulhart-Meynet MC et al. Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes. Pharmacogenet. Genomics 2010 Jul;20(7):455-8
Brulhart-Meynet MC et al
2010/01/01
Applications: WB PubMed
2 Sun XM et al. Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia. Hum. Mol. Genet. 2005 May;14(9):1161-9
Sun XM et al
2005/01/01
PubMed
3 Dub辿 E et al. Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta. Biol. Reprod. 2013 Jan;88(1):16
Dub辿 E et al
2013/01/01
PubMed
4 Lambert G et al. Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment. Clin. Chem. 2008 Jun;54(6):1038-45
Lambert G et al
2008/01/01
PubMed
5 Blesa S et al. A new PCSK9 gene promoter variant affects gene expression and causes autosomal dominant hypercholesterolemia. J. Clin. Endocrinol. Metab. 2008 Sep;93(9):3577-83
Blesa S et al
2008/01/01
PubMed
6 Dewpura T et al. PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans. FEBS J. 2008 Jul;275(13):3480-93
Dewpura T et al
2008/01/01
PubMed
7 Diebold I et al. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 2010 Jun;21(12):2087-96
Diebold I et al
2010/01/01
Applications: Chip, WB PubMed
8 Benjannet S et al. The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications. J. Biol. Chem. 2006 Oct;281(41):30561-72
Benjannet S et al
2006/01/01
PubMed
9 Cohen J et al. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 2005 Feb;37(2):161-5
Cohen J et al
2005/01/01
PubMed
10 Lebeau P et al. Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained. J. Biol. Chem. 2018 May;293(19):7329-7343
Lebeau P et al
2018/01/01
Species: Mouse PubMed
11 Lebeau P et al. Endoplasmic Reticulum Stress and Ca2+ Depletion Differentially Modulate the Sterol Regulatory Protein PCSK9 to Control Lipid Metabolism. J. Biol. Chem. 2017 01;292(4):1510-1523
Lebeau P et al
2017/01/01
PubMed
  • No.: 1
  • 文献情報:
    Brulhart-Meynet MC et al. Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes. Pharmacogenet. Genomics 2010 Jul;20(7):455-8
    Brulhart-Meynet MC et al
    2010/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sun XM et al. Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia. Hum. Mol. Genet. 2005 May;14(9):1161-9
    Sun XM et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Dub辿 E et al. Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta. Biol. Reprod. 2013 Jan;88(1):16
    Dub辿 E et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Lambert G et al. Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment. Clin. Chem. 2008 Jun;54(6):1038-45
    Lambert G et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Blesa S et al. A new PCSK9 gene promoter variant affects gene expression and causes autosomal dominant hypercholesterolemia. J. Clin. Endocrinol. Metab. 2008 Sep;93(9):3577-83
    Blesa S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Dewpura T et al. PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans. FEBS J. 2008 Jul;275(13):3480-93
    Dewpura T et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Diebold I et al. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 2010 Jun;21(12):2087-96
    Diebold I et al
    2010/01/01
  • 備考:
    Applications: Chip, WB
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Benjannet S et al. The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications. J. Biol. Chem. 2006 Oct;281(41):30561-72
    Benjannet S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Cohen J et al. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 2005 Feb;37(2):161-5
    Cohen J et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Lebeau P et al. Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained. J. Biol. Chem. 2018 May;293(19):7329-7343
    Lebeau P et al
    2018/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Lebeau P et al. Endoplasmic Reticulum Stress and Ca2+ Depletion Differentially Modulate the Sterol Regulatory Protein PCSK9 to Control Lipid Metabolism. J. Biol. Chem. 2017 01;292(4):1510-1523
    Lebeau P et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed